XML 50 R35.htm IDEA: XBRL DOCUMENT
v3.23.2

Segment Information (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2023
Notes Tables |
Schedule of financial information by reportable segment | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Year Ended June 30,
​ |  | 2023 |  | 2022 |  | 2021
Net sales: |  | ​ |  | ​ | ​ | ​ | ​ | ​ | ​
Protein Sciences | ​ | $ | 845,747 |  | $ | 832,311 | ​ | $ | 704,564
Diagnostics and Genomics | ​ |  | 292,602 | ​ |  | 274,843 | ​ |  | 227,744
Intersegment | ​ |  | (1,647) | ​ |  | (1,555) | ​ |  | (1,276)
Consolidated net sales | ​ | $ | 1,136,702 |  | $ | 1,105,599 | ​ | $ | 931,032
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Operating income: | ​ |  |  | ​ |  |  | ​ |  |
Protein Sciences | ​ | $ | 373,684 |  | $ | 377,623 | ​ | $ | 330,225
Diagnostics and Genomics | ​ |  | 43,037 | ​ |  | 48,977 | ​ |  | 38,425
Segment operating income | ​ |  | 416,721 | ​ |  | 426,600 | ​ |  | 368,650
Costs recognized on sale of acquired inventory | ​ |  | (400) | ​ |  | (1,596) | ​ |  | (1,565)
Amortization of intangibles | ​ |  | (76,413) | ​ |  | (73,054) | ​ |  | (64,239)
Impact of partially-owned consolidated subsidiaries(1) | ​ |  | 647 | ​ |  | (2,393) | ​ |  | (1,505)
Acquisition related expenses and other | ​ |  | 9,965 | ​ |  | 19,070 | ​ |  | (7,114)
Eminence impairment | ​ | ​ | — | ​ | ​ | (18,715) | ​ | ​ | —
Stock based compensation, inclusive of employer taxes | ​ |  | (41,217) | ​ |  | (46,401) | ​ |  | (51,846)
Restructuring costs | ​ |  | (3,829) | ​ |  | (1,640) | ​ |  | (142)
Corporate general, selling, and administrative expenses | ​ |  | (6,530) | ​ |  | (5,281) | ​ |  | (4,943)
Consolidated operating income | ​ | $ | 298,944 |  | $ | 296,590 | ​ | $ | 237,296
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Year Ended June 30,
​ |  | 2023 |  | 2022 |  | 2021
Consumables revenue - Protein Sciences | ​ | $ | 665,301 | ​ | $ | 646,952 | ​ | $ | 557,037
Consumables revenue - Diagnostics and Genomics | ​ |  | 252,432 | ​ |  | 243,922 | ​ |  | 194,948
Total consumable revenue | ​ | $ | 917,733 | ​ | $ | 890,874 | ​ | $ | 751,985
​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Year ended June 30,
​ |  | 2023 |  | 2022
Long-lived assets: | ​ | ​ | ​ | ​ | ​ | ​
United States and Canada | ​ | $ | 203,657 |  | $ | 203,732
Europe |  |  | 19,263 | ​ |  | 16,223
Asia | ​ |  | 3,280 | ​ |  | 3,287
Total long-lived assets | ​ | $ | 226,200 |  | $ | 223,242
Intangible assets: | ​ |  |  | ​ |  |
United States and Canada | ​ | $ | 529,652 |  | $ | 523,536
Europe | ​ |  | 4,553 | ​ |  | 6,281
Asia | ​ |  | 440 | ​ |  | 1,705
Total intangible assets | ​ | $ | 534,645 |  | $ | 531,522

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_TableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration